Ongoing Clinical Trials

  • A Randomized, Open-Label, Multi-Center, Phase 3 Study to Evaluate the Efficacy and Safety of AP301 on Serum Phosphorus Control in Chronic Kidney Disease Patients Receiving Maintenance Dialysis with Hyperphosphatemia
  • A Randomized, Double-Blind, Placebo-Controlled Multiple-Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AP303 Following 2-Week Oral Administration in Diabetic Kidney Disease Patients with Renal Impairment